Compassionate use of remdesir and convalescent plasma therapy for the treatment of COVID-19 infection in Nepal: a prospective observational study
Executive Summary: Background As of December 2020, the COVID-19 pandemic has infected over 80 million people and caused over 1.7 million deaths worldwide. Over 250 thousand cases of infection and over 1800 deaths have occurred in Nepal. An approved antiviral therapy for the treatment of COVID-19 i...
Збережено в:
Автори: | Gyanwali, Pradeep, Bhattarai, Saroj, Dhimal, Meghnath |
---|---|
Формат: | Technical Report |
Мова: | en_US |
Опубліковано: |
Nepal Health Research Council
2021
|
Предмети: | |
Онлайн доступ: | http://103.69.126.140:8080/handle/123456789/743 |
Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Схожі ресурси
-
Assessment of health status of home isolated COVID-19 patients in Nepal
за авторством: Gyanwali, Pradeep, та інші
Опубліковано: (2021) -
Assessment of status of post-recovery patients with COVID-19 infections in Nepal
за авторством: Gyanwali, Pradeep, та інші
Опубліковано: (2021) -
Compassionate use of remdesir and convalescent plasma therapy for the treatment of COVID-19 infection in Nepal: a prospective observational study.
Опубліковано: (2021) -
Responding to COVID-19: health sector preparedness, response and lessons learnt
Опубліковано: (2021) -
Covid-19: Effect of lockdown on mental and physical health.
за авторством: Gautam, Dikshya
Опубліковано: (2020)